TRAF2 facilitates vaccinia virus replication by promoting rapid virus entry

Journal of Virology

Volumn 88, Issue 7, 2014, Pages 3664-3677

  Haga, Ismar R ^a   Jowers, Tali Pechenick ^a   Griffiths, Samantha J ^b   Haas, Juergen ^b   Beard, Philippa M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; DNA VIRUS INFECTION; EMBRYO; ENZYME ACTIVATION; FIBROBLAST; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POXVIRUS VACCINIA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIROGENESIS; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INFECTION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS UNCOATING; WILD TYPE;

ANIMALS; CELL LINE; EPITHELIAL CELLS; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; GENE KNOCKOUT TECHNIQUES; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; TNF RECEPTOR-ASSOCIATED FACTOR 2; VACCINIA VIRUS; VIRUS INTERNALIZATION;

EID: 84895450532     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03013-13     Document Type: Article

References (81)

1. Bradley JR, Pober JS. 2001. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20:6482-6491. http://dx.doi.org/10.1038/sj .onc.1204788.
2. Oeckinghaus A, Hayden MS, Ghosh S. 2011. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 12:695-708. http://dx.doi.org/10 .1038/ni.2065.
3. Gentle IE, Wong WW, Evans JM, Bankovacki A, Cook WD, Khan NR, Nachbur U, Rickard J, Anderton H, Moulin M, Lluis JM, Moujalled DM, Silke J, Vaux DL. 2011. In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8. J. Biol. Chem. 286: 13282-13291. http://dx.doi.org/10.1074/jbc.M110.216226.
4. Gonzalvez F, Lawrence D, Yang B, Yee S, Pitti R, Marsters S, Pham VC, Stephan JP, Lill J, Ashkenazi A. 2012. TRAF2 sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. Mol. Cell 48:888-899. http://dx.doi.org/10.1016/j.molcel.2012.09.031.
5. Mikkelsen SS, Jensen SB, Chiliveru S, Melchjorsen J, Julkunen I, Gaestel M, Arthur JS, Flavell RA, Ghosh S, Paludan SR. 2009. RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1. J. Biol. Chem. 284:10774-10782. http://dx.doi.org/10.1074 /jbc.M807272200.
6. Schichl YM, Resch U, Lemberger CE, Stichlberger D, de Martin R. 2011. Novel phosphorylation-dependent ubiquitination of tristetraprolin by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1) and tumor necrosis factor receptor-associated factor 2 (TRAF2). J. Biol. Chem. 286:38466-38477. http://dx.doi.org/10 .1074/jbc.M111.254888.
7. Chadee DN, Yuasa T, Kyriakis JM. 2002. Direct activation of mitogenactivated protein kinase kinase kinase MEKK1 by the Ste20p homologue GCK and the adapter protein TRAF2. Mol. Cell. Biol. 22:737-749. http: //dx.doi.org/10.1128/MCB.22.3.737-749.2002.
8. Bogoyevitch MA, Kobe B. 2006. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol. Mol. Biol. Rev. 70:1061-1095. http://dx.doi.org/10.1128/MMBR.00025-06.
9. Krishna M, Narang H. 2008. The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell. Mol. Life Sci. 65:3525-3544. http://dx.doi.org/10.1007/s00018-008-8170-7.
10. Benn J, Su F, Doria M, Schneider RJ. 1996. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signalregulated and c-Jun N-terminal mitogen-activated protein kinases. J. Virol. 70:4978-4985.
11. Ceballos-Olvera I, Chavez-Salinas S, Medina F, Ludert JE, del Angel RM. 2010. JNK phosphorylation, induced during dengue virus infection, is important for viral infection and requires the presence of cholesterol. Virology 396:30-36. http://dx.doi.org/10.1016/j.virol.2009.10.019.
12. Holloway G, Coulson BS. 2006. Rotavirus activates JNK and p38 signaling pathways in intestinal cells, leading to AP-1-driven transcriptional responses and enhanced virus replication. J. Virol. 80:10624-10633. http: //dx.doi.org/10.1128/JVI.00390-06.
13. Pereira AC, Leite FG, Brasil BS, Soares-Martins JA, Torres AA, Pimenta PF, Souto-Padron T, Traktman P, Ferreira PC, Kroon EG, Bonjardim CA. 2012. A vaccinia virus-driven interplay between the MKK4/7-JNK1/2 pathway and cytoskeleton reorganization. J. Virol. 86:172-184. http://dx .doi.org/10.1128/JVI.05638-11.
14. Zachos G, Clements B, Conner J. 1999. Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1. J. Biol. Chem. 274: 5097-5103. http://dx.doi.org/10.1074/jbc.274.8.5097.
15. Moss B. 2007. Poxviridae: the viruses and their replication, p 2906-2945. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
16. Smith GL, Vanderplasschen A, Law M. 2002. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 83:2915-2931.
17. Law M, Carter GC, Roberts KL, Hollinshead M, Smith GL. 2006. Ligand-induced and nonfusogenic dissolution of a viral membrane. Proc. Natl. Acad. Sci. U. S. A. 103:5989-5994. http://dx.doi.org/10.1073/pnas .0601025103.
18. Carter GC, Law M, Hollinshead M, Smith GL. 2005. Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J. Gen. Virol. 86:1279-1290. http://dx.doi.org/10.1099/vir .0.80831-0.
19. Chung CS, Hsiao JC, Chang YS, Chang W. 1998. A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J. Virol. 72: 1577-1585.
20. Hsiao JC, Chung CS, Chang W. 1999. Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. J. Virol. 73:8750-8761.
21. Lin CL, Chung CS, Heine HG, Chang W. 2000. Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo. J. Virol. 74:3353-3365. http://dx.doi.org/10.1128/JVI.74.7.3353-3365.2000.
22. Armstrong JA, Metz DH, Young MR. 1973. The mode of entry of vaccinia virus into L cells. J. Gen. Virol. 21:533-537. http://dx.doi.org/10 .1099/0022-1317-21-3-533.
23. Doms RW, Blumenthal R, Moss B. 1990. Fusion of intra-and extracellular forms of vaccinia virus with the cell membrane. J. Virol. 64:4884-4892.
24. Mercer J, Helenius A. 2012. Gulping rather than sipping: macropinocytosis as a way of virus entry. Curr. Opin. Microbiol. 15:490-499. http://dx .doi.org/10.1016/j.mib.2012.05.016.
25. Moss B. 2012. Poxvirus cell entry: how many proteins does it take. Viruses 4:688-707. http://dx.doi.org/10.3390/v4050688.
26. Schmidt FI, Bleck CK, Mercer J. 2012. Poxvirus host cell entry. Curr. Opin. Virol. 2:20-27. http://dx.doi.org/10.1016/j.coviro.2011.11.007.
27. Bengali Z, Satheshkumar PS, Moss B. 2012. Orthopoxvirus species and strain differences in cell entry. Virology 433:506-512. http://dx.doi.org/10 .1016/j.virol.2012.08.044.
28. Chang SJ, Chang YX, Izmailyan R, Tang YL, Chang W. 2010. Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells. J. Virol. 84:8422-8432. http://dx.doi.org/10.1128/JVI.00599-10.
29. Mercer J, Knebel S, Schmidt FI, Crouse J, Burkard C, Helenius A. 2010. Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry. Proc. Natl. Acad. Sci. U. S. A. 107:9346-9351. http://dx.doi.org/10 .1073/pnas.1004618107.
30. Whitbeck JC, Foo C-H, Ponce de Leon M, Eisenberg RJ, Cohen GH. 2009. Vaccinia virus exhibits cell-type-dependent entry characteristics. Virology 385:383-391. http://dx.doi.org/10.1016/j.virol.2008.12.029.
31. Haga IR, Bowie AG. 2005. Evasion of innate immunity by vaccinia virus. Parasitology 130(Suppl):S11-S25. http://dx.doi.org/10.1017 /S0031182005008127.
32. de Magalhaes JC, Andrade AA, Silva PN, Sousa LP, Ropert C, Ferreira PC, Kroon EG, Gazzinelli RT, Bonjardim CA. 2001. A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ ERK and protein kinase A in virus multiplication. J. Biol. Chem. 276: 38353-38360. http://dx.doi.org/10.1074/jbc.M100183200.
33. Zhang P, Langland JO, Jacobs BL, Samuel CE. 2009. Protein kinase PKR-dependent activation of mitogen-activated protein kinases occurs through mitochondrial adapter IPS-1 and is antagonized by vaccinia virus E3L. J. Virol. 83:5718-5725. http://dx.doi.org/10.1128/JVI.00224-09.
34. Bablanian R, Baxt B, Sonnabend JA, Esteban M. 1978. Studies on the mechanisms of vaccinia virus cytopathic effects. II. Early cell rounding is associated with virus polypeptide synthesis. J. Gen. Virol. 39:403-413.
35. Sanderson CM, Smith GL. 1998. Vaccinia virus induces Ca2+-independent cell-matrix adhesion during the motile phase of infection. J. Virol. 72:9924-9933.
36. Sanderson CM, Way M, Smith GL. 1998. Virus-induced cell motility. J. Virol. 72:1235-1243.
37. Schepis A, Schramm B, de Haan CA, Locker JK. 2006. Vaccinia virusinduced microtubule-dependent cellular rearrangements. Traffic 7:308-323. http://dx.doi.org/10.1111/j.1600-0854.2005.00381.x.
38. Zwilling J, Sliva K, Schwantes A, Schnierle B, Sutter G. 2010. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virusinduced cell motility but not growth in human and murine cells. Virology 404:231-239. http://dx.doi.org/10.1016/j.virol.2010.05.008.
39. Cordeiro JV, Guerra S, Arakawa Y, Dodding MP, Esteban M, Way M. 2009. F11-mediated inhibition of RhoA signalling enhances the spread of vaccinia virus in vitro and in vivo in an intranasal mouse model of infection. PLoS One 4:e8506. http://dx.doi.org/10.1371/journal.pone.0008506.
40. Morales I, Carbajal MA, Bohn S, Holzer D, Kato SE, Greco FA, Moussatche N, Krijnse Locker J. 2008. The vaccinia virus F11L gene product facilitates cell detachment and promotes migration. Traffic 9:1283-1298. http://dx.doi.org/10.1111/j.1600-0854.2008.00762.x.
41. Valderrama F, Cordeiro JV, Schleich S, Frischknecht F, Way M. 2006. Vaccinia virus-induced cell motility requires F11L-mediated inhibition of RhoA signaling. Science 311:377-381. http://dx.doi.org/10.1126/science .1122411.
42. Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, de la Pompa JL, Ferrick D, Hum B, Iscove N, Ohashi P, Rothe M, Goeddel DV, Mak TW. 1997. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7:715-725. http://dx.doi.org/10.1016/S1074-7613(00)80391-X.
43. Carter GC, Rodger G, Murphy BJ, Law M, Krauss O, Hollinshead M, Smith GL. 2003. Vaccinia virus cores are transported on microtubules. J. Gen. Virol. 84:2443-2458. http://dx.doi.org/10.1099/vir.0.19271-0.
44. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45. http://dx.doi.org/10.1093 /nar/29.9.e45.
45. de Carvalho F, Costa ET, Camargo AA, Gregorio JC, Masotti C, Andrade VC, Strauss BE, Caballero OL, Atanackovic D, Colleoni GW. 2011. Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines. PLoS One 6:e27707. http://dx.doi.org/10.1371/journal.pone.0027707.
46. Richard J, Sindhu S, Pham TN, Belzile JP, Cohen EA. 2010. HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood 115:1354-1363. http://dx.doi .org/10.1182/blood-2009-08-237370.
47. Persano L, Pistollato F, Rampazzo E, Della Puppa A, Abbadi S, Frasson C, Volpin F, Indraccolo S, Scienza R, Basso G. 2012. BMP2 sensitizes glioblastoma stem-like cells to temozolomide by affecting HIF-1alpha stability andMGMTexpression. Cell Death Dis. 3:e412. http://dx.doi.org/10 .1038/cddis.2012.153.
48. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:RESEARCH0034. http://dx.doi.org/10.1186/gb-2002-3-7-research0034.
49. Law M, Smith GL. 2001. Antibody neutralization of the extracellular enveloped form of vaccinia virus. Virology 280:132-142. http://dx.doi.org /10.1006/viro.2000.0750.
50. Brown H, Prescott R. 2006. Applied mixed models in medicine. John Wiley & Sons Ltd, Chichester, United Kingdom.
51. Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, Kurt-Jones EA, Golenbock DT, Espevik T. 2002. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277:47834-47843. http://dx.doi.org/10.1074/jbc .M207873200.
52. Townsley AC, Weisberg AS, Wagenaar TR, Moss B. 2006. Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway. J. Virol. 80:8899-8908. http://dx.doi.org/10.1128/JVI.01053-06.
53. Stack J, Haga IR, Schroder M, Bartlett NW, Maloney G, Reading PC, Fitzgerald KA, Smith GL, Bowie AG. 2005. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 201:1007-1018. http://dx.doi.org/10.1084/jem .20041442.
54. Parkinson JE, Smith GL. 1994. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology 204:376-390. http://dx.doi.org/10.1006/viro.1994.1542.
55. Thomson TM, Benjamin KR, Bush A, Love T, Pincus D, Resnekov O, Yu RC, Gordon A, Colman-Lerner A, Endy D, Brent R. 2011. Scaffold number in yeast signaling system sets tradeoff between system output and dynamic range. Proc. Natl. Acad. Sci. U. S. A. 108:20265-20270. http://dx .doi.org/10.1073/pnas.1004042108.
56. Wang YV, Wade M, Wong E, Li YC, Rodewald LW, Wahl GM. 2007. Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation. Proc. Natl. Acad. Sci. U. S. A. 104:12365-12370. http://dx.doi.org/10.1073/pnas.0701497104.
57. Vanderplasschen A, Hollinshead M, Smith GL. 1998. Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J. Gen. Virol. 79(Pt 4):877-887.
58. Tada K, Okazaki T, Sakon S, Kobarai T, Kurosawa K, Yamaoka S, Hashimoto H, Mak TW, Yagita H, Okumura K, Yeh WC, Nakano H. 2001. Critical roles of TRAF2 and TRAF5 in tumor necrosis factorinduced NF-kappa B activation and protection from cell death. J. Biol. Chem. 276:36530-36534. http://dx.doi.org/10.1074/jbc.M104837200.
59. Blasco R, Sisler JR, Moss B. 1993. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene. J. Virol. 67:3319-3325.
60. Mercer J, Helenius A. 2008. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320:531-535. http://dx.doi .org/10.1126/science.1155164.
61. Bengali Z, Townsley AC, Moss B. 2009. Vaccinia virus strain differences in cell attachment and entry. Virology 389:132-140. http://dx.doi.org/10 .1016/j.virol.2009.04.012.
62. Pomerantz JL, Baltimore D. 1999. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 18:6694-6704. http://dx.doi.org/10.1093/emboj/18.23 .6694.
63. Habelhah H, Takahashi S, Cho SG, Kadoya T, Watanabe T, Ronai Z. 2004. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J. 23:322-332. http://dx .doi.org/10.1038/sj.emboj.7600044.
64. Lee TH, Huang Q, Oikemus S, Shank J, Ventura JJ, Cusson N, Vaillancourt RR, Su B, Davis RJ, Kelliher MA. 2003. The death domain kinase RIP1 is essential for tumor necrosis factor alpha signaling to p38 mitogen-activated protein kinase. Mol. Cell. Biol. 23:8377-8385. http: //dx.doi.org/10.1128/MCB.23.22.8377-8385.2003.
65. Castillo K, Rojas-Rivera D, Lisbona F, Caballero B, Nassif M, Court FA, Schuck S, Ibar C, Walter P, Sierralta J, Glavic A, Hetz C. 2011. BAX inhibitor-1 regulates autophagy by controlling the IRE1alpha branch of the unfolded protein response. EMBO J. 30:4465-4478. http://dx.doi.org /10.1038/emboj.2011.318.
66. Peng C, Zhu F, Wen W, Yao K, Li S, Zykova T, Liu K, Li X, Ma WY, Bode AM, Dong Z. 2012. Tumor necrosis factor receptor-associated factor family protein 2 is a key mediator of the epidermal growth factorinduced ribosomal S6 kinase 2/cAMP-responsive element-binding protein/ Fos protein signaling pathway. J. Biol. Chem. 287:25881-25892. http: //dx.doi.org/10.1074/jbc.M112.359521.
67. Payne LG. 1980. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J. Gen. Virol. 50:89-100. http: //dx.doi.org/10.1099/0022-1317-50-1-89.
68. Blasco R, Moss B. 1992. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread. J. Virol. 66:4170-4179.
69. McIntosh AA, Smith GL. 1996. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J. Virol. 70:272-281.
70. Huang CY, Lu TY, Bair CH, Chang YS, Jwo JK, Chang W. 2008. A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis. J. Virol. 82:7988-7999. http://dx .doi.org/10.1128/JVI.00894-08.
71. Izmailyan R, Hsao JC, Chung CS, Chen CH, Hsu PW, Liao CL, Chang W. 2012. Integrin beta1 mediates vaccinia virus entry through activation of PI3K/Akt signaling. J. Virol. 86:6677-6687. http://dx.doi.org/10.1128 /JVI.06860-11.
72. Schroeder N, Chung CS, Chen CH, Liao CL, Chang W. 2012. The lipid raft-associated protein CD98 is required for vaccinia virus endocytosis. J. Virol. 86:4868-4882. http://dx.doi.org/10.1128/JVI.06610-11.
73. Arakawa Y, Cordeiro JV, Schleich S, Newsome TP, Way M. 2007. The release of vaccinia virus from infected cells requires RhoA-mDia modulation of cortical actin. Cell Host Microbe 1:227-240. http://dx.doi.org/10 .1016/j.chom.2007.04.006.
74. Irwin CR, Evans DH. 2012. Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11. J. Virol. 86:7167-7179. http://dx .doi.org/10.1128/JVI.06936-11.
75. Hunter I, Nixon GF. 2006. Spatial compartmentalization of tumor necrosis factor (TNF) receptor 1-dependent signaling pathways in human airway smooth muscle cells. Lipid rafts are essential for TNF-alphamediated activation of RhoA but dispensable for the activation of the NF-kappaB and MAPK pathways. J. Biol. Chem. 281:34705-34715. http: //dx.doi.org/10.1074/jbc.M605738200.
76. Kakiashvili E, Dan Q, Vandermeer M, Zhang Y, Waheed F, Pham M, Szaszi K. 2011. The epidermal growth factor receptor mediates tumor necrosis factor-alpha-induced activation of the ERK/GEF-H1/RhoA pathway in tubular epithelium. J. Biol. Chem. 286:9268-9279. http://dx.doi .org/10.1074/jbc.M110.179903.
77. Nosaka Y, Arai A, Kanda E, Akasaki T, Sumimoto H, Miyasaka N, Miura O. 2001. Rac is activated by tumor necrosis factor alpha and is involved in activation of Erk. Biochem. Biophys. Res. Commun. 285:675-679. http://dx.doi.org/10.1006/bbrc.2001.5222.
78. Papakonstanti EA, Stournaras C. 2004. Tumor necrosis factor-alpha promotes survival of opossum kidney cells via Cdc42-induced phospholipase C-gamma1 activation and actin filament redistribution. Mol. Biol. Cell 15:1273-1286. http://dx.doi.org/10.1091/mbc.E03-07-0491.
79. Puls A, Eliopoulos AG, Nobes CD, Bridges T, Young LS, Hall A. 1999. Activation of the small GTPase Cdc42 by the inflammatory cytokines TNF(alpha) and IL-1, and by the Epstein-Barr virus transforming protein LMP1. J. Cell Sci. 112(Pt 17):2983-2992.
80. Waheed F, Dan Q, Amoozadeh Y, Zhang Y, Tanimura S, Speight P, Kapus A, Szaszi K. 2013. Central role of the exchange factor GEF-H1 in TNF-alpha-induced sequential activation of Rac, ADAM17/TACE, and RhoA in tubular epithelial cells. Mol. Biol. Cell 24:1068-1082. http://dx .doi.org/10.1091/mbc.E12-09-0661.
81. Kumar A, Byun HS, Bittman R, Saba JD. 2011. The sphingolipid degradation product trans-2-hexadecenal induces cytoskeletal reorganization and apoptosis in a JNK-dependent manner. Cell Signal. 23:1144-1152. http://dx.doi.org/10.1016/j.cellsig.2011.02.009.